With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling high-risk, high-reward investment. Read more on ATYR stock here.

Topical solutions may help, but never put creams on lesions that ... including dry skin, allergic reactions, eczema, bug bites, and chronic conditions like multiple sclerosis.

Treatment with Tysabri (natalizumab) may help delay disability progression in people with secondary progressive multiple sclerosis (SPMS) over Rebif (interferon beta ...

The law firm Kalfus & Nachman will host a special event to raise funds for multiple sclerosis (MS) research, patient care, advocacy, and increasing disease awareness. The fundraising will be held ...

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

More information: Allan Motyer et al, Neuronal somatic mutations are increased in multiple sclerosis lesions, Nature Neuroscience (2025). DOI: 10.1038/s41593-025-01895-5 ...

Multiple sclerosis causes lesions to the spinal cord and other parts of the central nervous system. An MRI can detect spinal cord lesions and help diagnose and monitor the condition. Multiple ...

WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of ...

They most commonly occur in people with multiple sclerosis (MS ... a Scottish pathologist who first identified these elongated lesions in the early part of the 20th century.

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...